Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy Medical Dialogues Bureau8 July 2019 8:02 AM GMTAs part of the diversification and new market entry strategy, DRL (Dr Reddys) plans to re-focus some of its Research and Development resources to...